Cargando…
Platinum drugs-related safety profile: The latest five-year analysis from FDA adverse event reporting system data
BACKGROUND: With the widespread application of platinum drugs in antitumor therapy, the incidence of platinum drug adverse events (ADEs) is always severe. This study aimed to explore the adverse event signals of Cisplatin, Carboplatin and Oxaliplatin, three widely used platinum-containing drugs, and...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875054/ https://www.ncbi.nlm.nih.gov/pubmed/36713566 http://dx.doi.org/10.3389/fonc.2022.1012093 |